Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Caroline Holm Nørgaard"'
Autor:
Caroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, Thomas Gerds, Clive Ballard, Daniel Vega Møller, Lotte Bjerre Knudsen, Kajsa Kvist, Bernard Zinman, Ellen Holm, Christian Torp‐Pedersen, Lina Steinrud Mørch
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 8, Iss 1, Pp n/a-n/a (2022)
Abstract Introduction People with type 2 diabetes have increased risk of dementia. Glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are among the promising therapies for repurposing as a treatment for Alzheimer's disease; a key unanswere
Externí odkaz:
https://doaj.org/article/a3a27f9ddbfd4e1cafdac0c2aea95168
Autor:
Caroline Holm Nørgaard, Nikoline Buus Søgaard, Jorne Lionel Biccler, Laura Pilgaard, Mathias Holmsgaard Eskesen, Thordis Helga Kjartansdottir, Martin Bøgsted, Tarec Christoffer El-Galaly
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208180 (2018)
IntroductionThe majority of newly diagnosed chronic lymphocytic leukemia (CLL) patients are followed initially by watch and wait (WAW). Clinical practice varies and the value of frequent follow-up visits remains unclear. Thus, in this study we invest
Externí odkaz:
https://doaj.org/article/4149c58c86744a6ab59f042e81cc4f67
Autor:
Caroline Holm Nørgaard, Lasse Hjort Jakobsen, Andrew J Gentles, Karen Dybkær, Tarec Christoffer El-Galaly, Julie Støve Bødker, Alexander Schmitz, Preben Johansen, Tobias Herold, Karsten Spiekermann, Jennifer R Brown, Josephine L Klitgaard, Hans Erik Johnsen, Martin Bøgsted
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193249 (2018)
Diagnostic and prognostic evaluation of chronic lymphocytic leukemia (CLL) involves blood cell counts, immunophenotyping, IgVH mutation status, and cytogenetic analyses. We generated B-cell associated gene-signatures (BAGS) based on six naturally occ
Externí odkaz:
https://doaj.org/article/54d6f02da4e545279292e8d9f730b34d
Autor:
Christina J.-Y. Lee, Anders Nissen Bonde, Liis Starkopf, Nathan D. Wong, Caroline Holm Nørgaard, Christian Torp-Pedersen, Lars Køber, Emil L. Fosbøl, Peter Vestergaard, Thomas A. Gerds
Publikováno v:
Nørgaard, C H, Starkopf, L, Gerds, T A, Vestergaard, P, Bonde, A N, Fosbøl, E, Køber, L, Wong, N D, Torp-Pedersen, C & Lee, C J-Y 2022, ' Cardiovascular Outcomes with GLP-1 Receptor Agonists Versus SGLT-2 Inhibitors in Patients with Type 2 Diabetes ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 6, pvab053, pp. 549–556 . https://doi.org/10.1093/ehjcvp/pvab053
Aims We examined cardiovascular outcomes associated with initiation of glucagon-like peptide-1 receptor agonist (GLP-1RA) vs. sodium–glucose co-transporter-2 inhibitor (SGLT-2i) treatment in a real-world setting among patients with type 2 diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0070252004e2bae532029123ba6461c0
https://doi.org/10.1093/ehjcvp/pvab053
https://doi.org/10.1093/ehjcvp/pvab053
Autor:
Caroline Kistorp, M. D. Schmiegelow, Morten Malmborg, Caroline Holm Nørgaard, Thomas A. Gerds, Morten Schou, Gunnar Gislason, Anders Munch, Christian Torp-Pedersen, Mark A. Hlatky
Publikováno v:
European Heart Journal
Malmborg, M, Schmiegelow, M D S, Nørgaard, C H, Munch, A, Gerds, T, Schou, M, Kistorp, C, Torp-Pedersen, C, Hlatky, M A & Gislason, G 2020, ' Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men? ', European Heart Journal, vol. 41, no. 13, pp. 1346–1353 . https://doi.org/10.1093/eurheartj/ehz913
Malmborg, M, Schmiegelow, M D S, Norgaard, C H, Munch, A, Gerds, T, Schou, M, Kistorp, C, Torp-Pedersen, C, Hlatky, M A & Gislason, G 2020, ' Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men? ', European Heart Journal, vol. 41, no. 13, pp. 1346-1353 . https://doi.org/10.1093/eurheartj/ehz913
Malmborg, M, Schmiegelow, M D S, Nørgaard, C H, Munch, A, Gerds, T, Schou, M, Kistorp, C, Torp-Pedersen, C, Hlatky, M A & Gislason, G 2020, ' Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men? ', European Heart Journal, vol. 41, no. 13, pp. 1346–1353 . https://doi.org/10.1093/eurheartj/ehz913
Malmborg, M, Schmiegelow, M D S, Norgaard, C H, Munch, A, Gerds, T, Schou, M, Kistorp, C, Torp-Pedersen, C, Hlatky, M A & Gislason, G 2020, ' Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men? ', European Heart Journal, vol. 41, no. 13, pp. 1346-1353 . https://doi.org/10.1093/eurheartj/ehz913
Aims To investigate whether diabetes confers higher relative rates of cardiovascular events in women compared with men using contemporary data, and whether these sex-differences depend on age. Methods and results All Danish residents aged 40–89 yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab28f285c0c387874af0c4571c5c1c01
http://europepmc.org/articles/PMC7109603
http://europepmc.org/articles/PMC7109603
Autor:
Caroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, Thomas Gerds, Clive Ballard, Daniel Vega Møller, Lotte Bjerre Knudsen, Kajsa Kvist, Bernard Zinman, Ellen Holm, Christian Torp‐Pedersen, Lina Steinrud Mørch
Publikováno v:
Norgaard, C H, Friedrich, S, Hansen, C T, Gerds, T, Ballard, C, Moller, D V, Knudsen, L B, Kvist, K, Zinman, B, Holm, E, Torp-Pedersen, C & Morch, L S 2022, ' Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia : Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers ', Alzheimers & dementia-Translational research & clinical interventions, vol. 8, no. 1, 12268 . https://doi.org/10.1002/trc2.12268
Nørgaard, C H, Friedrich, S, Hansen, C T, Gerds, T, Ballard, C, Møller, D V, Knudsen, L B, Kvist, K, Zinman, B, Holm, E, Torp-Pedersen, C & Mørch, L S 2022, ' Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia : Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers ', Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), vol. 8, no. 1, e12268 . https://doi.org/10.1002/trc2.12268
Nørgaard, C H, Friedrich, S, Hansen, C T, Gerds, T, Ballard, C, Møller, D V, Knudsen, L B, Kvist, K, Zinman, B, Holm, E, Torp-Pedersen, C & Mørch, L S 2022, ' Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia : Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers ', Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), vol. 8, no. 1, e12268 . https://doi.org/10.1002/trc2.12268
IntroductionPeople with type 2 diabetes have increased risk of dementia. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are among the promising therapies for repurposing as a treatment for Alzheimer's disease; a key unanswered question is wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f820cfefe48bc2aa8b8ef05a600463b0
https://pubmed.ncbi.nlm.nih.gov/35229024
https://pubmed.ncbi.nlm.nih.gov/35229024
Autor:
Bernard Zinman, Daniel Vega Møller, Ellen Holm, Charlotte T. Hansen, Clive Ballard, Kajsa Kvist, Lotte Bjerre Knudsen, Christian Torp-Pedersen, Sarah Friedrich, Caroline Holm Nørgaard, Lina Mørch, Thomas A. Gerds
Publikováno v:
Alzheimer's & Dementia. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::917edcfcf36add7ca739420a812b589e
https://doi.org/10.1002/alz.042909
https://doi.org/10.1002/alz.042909
Autor:
Christian Torp-Pedersen, Bochra Zareini, Søren Lund Kristensen, Morten Schou, Caroline Holm Nørgaard, Paul Blanche, Lars Køber, Gunnar Gislason, Christian Selmer, Morten Lamberts, Mariam Elmegaard Malik, Maria D'Souza
Publikováno v:
Zareini, B, Blanche, P, D'Souza, M, Elmegaard Malik, M, Nørgaard, C H, Selmer, C, Gislason, G, Kristensen, S L, Køber, L, Torp-Pedersen, C, Schou, M & Lamberts, M 2020, ' Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases : A Nationwide Study ', Circulation: Cardiovascular Quality and Outcomes, vol. 13, no. 7, e006260, pp. 386-394 . https://doi.org/10.1161/CIRCOUTCOMES.119.006260
Background: Heart failure (HF) in patients with type 2 diabetes mellitus (T2D) has received growing attention. We examined the effect of HF development on prognosis compared with other cardiovascular or renal diagnoses in patients with T2D. Methods a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c6d8d7b294f1d85dc9250c201f3e01
https://doi.org/10.1161/circoutcomes.119.006260
https://doi.org/10.1161/circoutcomes.119.006260
Autor:
Mitra Mosslemi, Christian Torp-Pedersen, Christina Ji-Young Lee, Caroline Holm Nørgaard, Nathan D. Wong
Publikováno v:
Nørgaard, C H, Mosslemi, M, Lee, C J-Y, Torp-Pedersen, C & Wong, N D 2019, ' The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes ', Current Cardiology Reports, vol. 21, no. 5, 35 . https://doi.org/10.1007/s11886-019-1123-y
PURPOSE OF REVIEW: The importance of composite risk factor control for reducing CVD risk in type 2 diabetes (T2DM) has gained increased attention and here we review the latest findings in the field.RECENT FINDINGS: The Steno-2 study was the first to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6c03b361cfd701d373a8bc7fb468e7
https://vbn.aau.dk/da/publications/cbd871a1-3666-4018-9b6d-73832fd8beb1
https://vbn.aau.dk/da/publications/cbd871a1-3666-4018-9b6d-73832fd8beb1
Autor:
Charlotte Pawlyn, Hanne Due, Mehmet Kemal Samur, Annemiek Broyl, Charles Vesteghem, Ditte Starberg Jespersen, Julie Støve Bødker, Uta Bertsch, Faith E. Davies, Anna Amanda Schönherz, Nikhil C. Munshi, Martin Agge Nørgaard, Martin Perez-Andres, Alberto Orfao, Gareth J. Morgan, Rasmus Froberg Brøndum, Tarec Christoffer El-Galaly, Martin Kaiser, Alexander Schmitz, Brian A Walker, Hans Erik Johnson, Pieter Sonneveld, Martin Bøgsted, Rajen D. Shah, Hartmut Goldschmidt, Mads Sønderkær, Karen Dybkær, Richard J. Samworth, Mark van Duin, Preben Johansen, Caroline Holm Nørgaard, David W. Johnson
Publikováno v:
Bødker, J S, Brøndum, R F, Schmitz, A, Schönherz, A A, Jespersen, D S, Sønderkær, M, Vesteghem, C, Due, H, Nørgaard, C H, Perez-Andres, M, Samur, M K, Davies, F, Walker, B, Pawlyn, C, Kaiser, M, Johnson, D, Bertsch, U, Broyl, A, van Duin, M, Shah, R, Johansen, P, Nørgaard, M A, Samworth, R J, Sonneveld, P, Goldschmidt, H, Morgan, G J, Orfao, A, Munshi, N, Johnsen, H E, El-Galaly, T, Dybkær, K & Bøgsted, M 2018, ' A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis ', Blood advances, vol. 2, no. 18, pp. 2400-2411 . https://doi.org/10.1182/bloodadvances.2018018564
Blood advances, 2(18), 2400-2411. American Society of Hematology
Bødker, J S, Brøndum, R F, Schmitz, A, Schönherz, A A, Jespersen, D S, Sønderkær, M, Vesteghem, C, Due, H, Nørgaard, C H, Perez-Andres, M, Samur, M K, Davies, F, Walker, B, Pawlyn, C, Kaiser, M, Johnson, D, Bertsch, U, Broyl, A, van Duin, M, Shah, R, Johansen, P, Nørgaard, M A, Samworth, R J, Sonneveld, P, Goldschmidt, H, Morgan, G J, Orfao, A, Munshi, N, Johnson, H E, El-Galaly, T, Dybkær, K & Bøgsted, M 2018, ' A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis ' Blood Advances, vol. 2, no. 18, pp. 2400-2411 . https://doi.org/10.1182/bloodadvances.2018018564
Blood advances, 2(18), 2400-2411. American Society of Hematology
Bødker, J S, Brøndum, R F, Schmitz, A, Schönherz, A A, Jespersen, D S, Sønderkær, M, Vesteghem, C, Due, H, Nørgaard, C H, Perez-Andres, M, Samur, M K, Davies, F, Walker, B, Pawlyn, C, Kaiser, M, Johnson, D, Bertsch, U, Broyl, A, van Duin, M, Shah, R, Johansen, P, Nørgaard, M A, Samworth, R J, Sonneveld, P, Goldschmidt, H, Morgan, G J, Orfao, A, Munshi, N, Johnson, H E, El-Galaly, T, Dybkær, K & Bøgsted, M 2018, ' A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis ' Blood Advances, vol. 2, no. 18, pp. 2400-2411 . https://doi.org/10.1182/bloodadvances.2018018564
Despite the recent progress in treatment of multiple myeloma (MM), it is still an incurable malignant disease, and we are therefore in need of new risk stratification tools that can help us to understand the disease and optimize therapy. Here we prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e42706263254e82e9e883353b837adc9
https://vbn.aau.dk/da/publications/3aa38799-da66-45ad-8dbd-85e69ccdc4b9
https://vbn.aau.dk/da/publications/3aa38799-da66-45ad-8dbd-85e69ccdc4b9